These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2619984)

  • 1. The WHO Psychological Impairments Rating Schedule (WHO/PIRS). II. Impairments in Schizophrenics in cross-sectional and longitudinal perspective--the Mannheim experience in two independent samples.
    Biehl H; Maurer K; Jung E; Krumm B
    Br J Psychiatry Suppl; 1989 Nov; (7):71-7. PubMed ID: 2619984
    [No Abstract]   [Full Text] [Related]  

  • 2. The WHO Psychological Impairments Rating Schedule (WHO/PIRS). I. Introducing a new instrument for rating observed behaviour and the rationale of the psychological impairment concept.
    Biehl H; Maurer K; Jablensky A; Cooper JE; Tomov T
    Br J Psychiatry Suppl; 1989 Nov; (7):68-70. PubMed ID: 2619983
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioural Observation Schedule (BOS), PIRS 2nd edition. A revised edition of the PIRS (WHO, Geneva, March 1978).
    Atakan Z; Cooper JE
    Br J Psychiatry Suppl; 1989 Nov; (7):78-88. PubMed ID: 2619985
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evolution of schizophrenia: role of symptomatology in the reliability of 11 diagnostic systems for schizophrenia].
    Dollfus S; Petit M; Menard JF; Lesieur P
    Ann Med Psychol (Paris); 1993 Apr; 151(4):322-5. PubMed ID: 8285501
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparing the sensitivity of generic effectiveness measures with symptom improvement in persons with schizophrenia.
    Pyne JM; Sullivan G; Kaplan R; Williams DK
    Med Care; 2003 Feb; 41(2):208-17. PubMed ID: 12555049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranking of outcome domains for use in real-time outcomes feedback laboratory by patients with schizophrenia.
    Pyne JM; Labbate C
    J Nerv Ment Dis; 2008 Apr; 196(4):336-9. PubMed ID: 18414130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rating of negative symptoms using the High Royds Evaluation of Negativity (HEN) scale.
    Mortimer AM; McKenna PJ; Lund CE; Mannuzza S
    Br J Psychiatry Suppl; 1989 Nov; (7):89-92. PubMed ID: 2619986
    [No Abstract]   [Full Text] [Related]  

  • 8. The diagnosis and understanding of schizophrenia. Summary and conclusions.
    Strauss JS; Carpenter WT; Bartko JJ
    Schizophr Bull; 1974; (11):70-80. PubMed ID: 4619922
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
    Brissos S; Dias VV; Carita AI; Martinez-Arán A
    Psychiatry Res; 2008 Jul; 160(1):55-62. PubMed ID: 18485488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thought disorder and schizophrenia.
    Cancro R
    Dis Nerv Syst; 1968 Dec; 29(12):846-9. PubMed ID: 5717301
    [No Abstract]   [Full Text] [Related]  

  • 11. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hopelessness in schizophrenia: the impact of symptoms and beliefs about illness.
    White RG; McCleery M; Gumley AI; Mulholland C
    J Nerv Ment Dis; 2007 Dec; 195(12):968-75. PubMed ID: 18091189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anhedonia in schizophrenia].
    Loas G; Boyer P; Legrand A; Gayant C; Delahousse J
    Encephale; 1995; 21(6):453-7. PubMed ID: 8674470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia.
    Tibbo P; Swainson J; Chue P; LeMelledo JM
    Depress Anxiety; 2003; 17(2):65-72. PubMed ID: 12621594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of Antonovsky's sense of coherence in patients with schizophrenia and its relationship to psychopathology.
    Bengtsson-Tops A; Brunt D; Rask M
    Scand J Caring Sci; 2005 Sep; 19(3):280-7. PubMed ID: 16101857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sex differences in schizophrenia].
    Häfner H; Gattaz WF
    Gynakologe; 1995 Dec; 28(6):426-33. PubMed ID: 8566873
    [No Abstract]   [Full Text] [Related]  

  • 18. [InSka (Intentionality Scale)--a new psychopathometric instrument for the detection of schizophrenic residual symptoms].
    Mundt C; Fiedler P; Pracht B; Rettig R
    Nervenarzt; 1985 Mar; 56(3):146-9. PubMed ID: 3990882
    [No Abstract]   [Full Text] [Related]  

  • 19. [The disease "picture" of schizophrenia. Change due to operational diagnostic systems and effects on research in epidemiology and disease course].
    Steinert T
    Psychiatr Prax; 1998 Jan; 25(1):3-8. PubMed ID: 9530761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of early schizophrenia. Influence of age and gender on onset and early course.
    Häfner H; Maurer K; Löffler W; Fätkenheuer B; an der Heiden W; Riecher-Rössler A; Behrens S; Gattaz WF
    Br J Psychiatry Suppl; 1994 Apr; (23):29-38. PubMed ID: 8037899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.